Entropic pressure controls the oligomerization of the Vibrio cholerae ParD2 antitoxin by Garcia-Rodriguez, G et al.
research papers
904 https://doi.org/10.1107/S2059798321004873 Acta Cryst. (2021). D77, 904–920
Received 4 March 2021
Accepted 7 May 2021
Edited by Z. S. Derewenda, University of
Virginia, USA
‡ GG-R and YG contributed equally and should
be considered joint first authors of this work.
Keywords: toxin–antitoxin module; ParD2;
Vibrio cholerae; intrinsically disordered
proteins; transcription regulation; oligomer
interface; protein–DNA interactions; protein
oligomers; quaternary structure.
PDB reference: N-terminal domain of ParD2,
7b22
Supporting information: this article has
supporting information at journals.iucr.org/d
Entropic pressure controls the oligomerization of
the Vibrio cholerae ParD2 antitoxin
Gabriela Garcia-Rodriguez,a,b‡ Yana Girardin,a,b‡ Alexander N. Volkov,a,b,c
Ranjan Kumar Singh,a,b Gopinath Muruganandam,a,b Jeroen Van Dyck,d Frank
Sobott,d,e Wim Versées,a,b Daniel Charlierf and Remy Lorisa,b*
aStructural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium, bVIB–VUB Center for
Structural Biology, Vlaams Instituut voor Biotechnologie, Pleinlaan 2, 1050 Brussels, Belgium, cJean Jeener NMR Center,
Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium, dDepartment of Chemistry, Universiteit Antwerpen,
Groenenborgerlaan 171, 2020 Antwerp, Belgium, eAstbury Centre for Structural Molecular Biology, University of Leeds,
Leeds LS2 9JT, United Kingdom, and fResearch Group of Microbiology, Vrije Universiteit Brussel, Pleinlaan 2, 1050
Brussels, Belgium. *Correspondence e-mail: remy.loris@vub.be
ParD2 is the antitoxin component of the parDE2 toxin–antitoxin module from
Vibrio cholerae and consists of an ordered DNA-binding domain followed by an
intrinsically disordered ParE-neutralizing domain. In the absence of the
C-terminal intrinsically disordered protein (IDP) domain, V. cholerae ParD2
(VcParD2) crystallizes as a doughnut-shaped hexadecamer formed by the
association of eight dimers. This assembly is stabilized via hydrogen bonds and
salt bridges rather than by hydrophobic contacts. In solution, oligomerization of
the full-length protein is restricted to a stable, open decamer or dodecamer,
which is likely to be a consequence of entropic pressure from the IDP tails. The
relative positioning of successive VcParD2 dimers mimics the arrangement of
Streptococcus agalactiae CopG dimers on their operator and allows an extended
operator to wrap around the VcParD2 oligomer.
1. Introduction
Like all organisms, bacteria have to deal with various kinds of
stress that threaten their survival. These include nutrient
starvation, chemical stress arising from compounds, including
antibiotic or redox stress, and physical stress such as heat or
salt. To deal with this, they have developed different strategies,
including the generation of persister cells, a specific stochas-
tically induced dormant metabolic state that allows a sub-
population to survive antibiotics to which they are not
resistant. Among the potential players in the bacterial stress-
response network are sets of small two-gene operons encoding
a toxic protein and a corresponding neutralizing protein or
RNA, known as toxin–antitoxin (TA) modules. They are often
abundant in free-living bacteria and opportunistic pathogens
(Pandey & Gerdes, 2005). For example, the well known
Mycobacterium tuberculosis contains at least 88 such modules,
while the closely related M. smegmatis only contains five
(Shao et al., 2011).
The physiological role of toxin–antitoxin modules has been
greatly debated. One of their potential functions is the stabi-
lization of mobile genetic elements (Gerdes et al., 1986;
Szekeres et al., 2007). After initially having been observed as
stabilizing elements on low-copy-number plasmids, TA
modules were also found on chromosomal regions that do not
encode essential genes, including integrative and conjugative
elements, the superintegrons of Vibrio cholerae and V. vulni-
ficus, chromosome II, cryptic prophages and genomic and
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pathogenicity islands (Dı́az-Orejas et al., 2017; Yao et al.,
2018).
The most popular proposed function for TA modules is
stress response (Gerdes, 2000; Gerdes et al., 2005; Hõrak &
Tamman, 2017). Indeed, the activity of TA toxins is upregu-
lated during episodes of stress. This was initially proposed to
be a consequence of the protease-dependent degradation of
antitoxins, a mechanism that has recently been challenged
(LeRoux et al., 2020; Song & Wood, 2020a). Furthermore, it
remains unclear whether stress-related TA activation is an
integral part of the stress-response network or whether it is
rather a side effect of the SOS response, which is the general
bacterial response to DNA damage (Little & Mount, 1982).
Equally, the supposed role of TA modules in the onset of
persistence remains unclear (Ronneau & Helaine, 2019).
Another function that has been attributed to TA modules is
protection against bacteriophages via abortive infection
(Fineran, 2019; Lopatina et al., 2020; Song & Wood, 2020b).
Last but not least, it should be considered that TA modules
might be mere selfish genetic elements that have adapted and
been conserved in a number of cases because they provide
some additional beneficial properties such as the functions
described above.
Toxin–antitoxin modules have been divided into eight
classes based on the nature of the antitoxin (protein or RNA)
and the mechanism by which it counteracts the toxin (Page &
Peti, 2016; Song & Wood, 2020a). The most common and best-
studied class of toxin–antitoxin modules are the type II
modules, in which the antitoxin encodes a protein that coun-
teracts the toxin via the formation of a tight noncovalent
complex. Type II modules can be further classified into an
increasing number of nonrelated families. Among these, the
parDE family of TA modules, although one of the first families
to be discovered, has been relatively understudied (Roberts &
Helinski, 1992). For two members, parDE from Escherichia
coli plasmid RK2 and parDE2 from V. cholerae, the target of
the ParE toxin was identified as gyrase (Jiang et al., 2002; Yuan
et al., 2010). Like the more intensively studied CcdB, ParE
poisons gyrase by stabilizing the so-called cleavable complex
between gyrase and DNA. This leads to double-strand breaks,
activation of the SOS response and ultimately, if the ParE
toxin is not counteracted by the antitoxin ParD, cell death.
Currently, the Protein Data Bank (PDB) contains an NMR
structure of ParD from plasmid RK2, an NMR structure of
E. coli PaaA2, which is a truncated ParD protein lacking a
DNA-binding domain, and crystal structures of ParD–ParE
complexes from Caulobacter crescentus and Mesorhizobium
opportunistum and of the PaaA2–ParE2 complex from the
parDE-like paaR2–paaA2–parE2 module of E. coli O157:H7
(Oberer et al., 2007; Sterckx et al., 2014, 2016; Dalton &
Crosson, 2010; Aakre et al., 2015). The target has not been
identified for either of the ParE proteins, and evidence has
been presented that E. coli ParE2 does not interact with the
DNA gyrase A subunit (Sterckx et al., 2016). Plasmid RK2,
M. opportunistum and C. crescentus ParD fold into an
N-terminal ribbon–helix–helix DNA-binding domain that is
followed by a domain which is unfolded in solution in plasmid
RK2 ParD but folds into a helix–helix–strand conformation
that wraps around the ParE toxin in C. crescentus and
M. opportunistum ParD. E. coli PaaA2 lacks the N-terminal
DNA-binding domain and is mostly disordered in solution, but
adopts the same conformation as the C-terminal domain of
C. crescentus or M. opportunistum ParD when bound to its
cognate ParE2.
The genome of V. cholerae contains three parDE modules,
all of which are located in the superintegron on chromosome
II (Yuan et al., 2011). The parDE1 and parDE3 modules have
identical open reading frames and regulatory sequences, while
the ParD and ParE proteins encoded by the parDE2 module
share 14% and 22% sequence identity, respectively, with their
parDE1/parDE3 counterparts. ParE2 has been shown to
inhibit gyrase in vitro and to bind to an epitope on the gyrase
A subunit that differs from the one targeted by F-plasmid
CcdB (Yuan et al., 2010). In vivo, both ParE1/ParE3 and
ParE2 inhibit cell division, activate the SOS response and
contribute to the degradation of chromosome I upon the loss
of chromosome II.
Transcriptional regulation of TA modules is often complex
and involves ratio-dependent interplay between the toxin and
antitoxin (Garcia-Pino et al., 2010; Yamaguchi & Inouye, 2011;
Jurėnas et al., 2019; Page & Peti, 2016; Vandervelde et al., 2017;
Xue et al., 2020). Intrinsically disordered segments on the
antitoxin or toxin often play a major role in these mechanisms
(De Jonge et al., 2009; Garcia-Pino et al., 2016; Loris & Garcia-
Pino, 2014; Talavera et al., 2019; De Bruyn et al., 2021). Little
information has been obtained, however, on the regulation
of parDE modules. Early work on plasmid RK2 parDE
suggested that ParD alone can act as a repressor of the operon
(Roberts et al., 1993), but it is not known whether the ParE
toxin modulates this action. Here, we describe the crystal
structure of V. cholerae ParD2 (VcParD2) and show that inter-
dimer contacts in the crystal mimic the functional arrangement
of the structurally related Streptococcus agalactiae CopG
bound to its DNA target (PDB entry 1b01; Gomis-Rüth et al.,
1998). While a doughnut-shaped hexadecamer is observed in
the crystal, in solution smaller decamers and dodecamers are
present that form a partial doughnut with otherwise similar
inter-subunit contacts. The partial disruption of the full
hexadecameric ring may possibly be attributed to steric
pressure from the intrinsically disordered C-terminal tails that
are absent in the crystallized entity.
2. Materials and methods
2.1. Expression and purification
The coding region of the V. cholerae parDE2 operon was
cloned into pET-28a, placing a T7 promotor upstream of the
parD2 gene and adding a His tag to the C-terminus of
VcParE2. E. coli BL21 (DE3) cells were transformed with this
vector and grown at 37C in lysogeny broth supplemented
with 50 mg ml1 kanamycin. Expression was induced at an
OD600 of 0.6 by adding 0.5 mM isopropyl -d-1-thiogalacto-
pyranoside. The cultures were incubated overnight at 20C,
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after which the cells were harvested by centrifugation at
5000 rev min1 and 4C for 15 min.
The cells were resuspended in 20 mM Tris pH 8.0, 500 mM
NaCl, 2 mM -mercaptoethanol and lysed with a cell cracker
after adding 50 mg ml1 DNase and 2 mM MgCl2. After
centrifugation at 19 500 rev min1 and 4C for 35 min, the
supernatant was filtered using a 0.45 mm filter and then loaded
onto a 5 ml HisTrap HP Nickel Sepharose column (GE
Healthcare) equilibrated with the same buffer. The column
was washed with 20 mM Tris pH 8.0, 500 mM NaCl, 2 mM
-mercaptoethanol, and the VcParD2–VcParE2 complex was
subsequently eluted using a step gradient of imidazole (0, 10,
25, 50, 250 and 500 mM) in the same buffer. The resulting
samples were loaded onto a Superdex 200 16/90 size-exclusion
chromatography (SEC) column (GE Healthcare) pre-equili-
brated with 20 mM Tris pH 8.0, 500 mM NaCl, 2 mM -
mercaptoethanol to obtain pure VcParD2–VcParE2 complex.
The VcParD2–VcParE2 complex was reloaded onto a
Ni–NTA column followed by washing with 20 mM Tris pH 8.0,
0.5 M NaCl, 10% ethylene glycol. VcParD2 was eluted by
applying a step gradient of guanidinium hydrochloride
(GndHCl; 0, 2.5 and 5 M) in 20 mM Tris pH 8.0, 500 mM NaCl,
2 mM -mercaptoethanol. The resulting VcParD2 fractions
were pooled and dialyzed against 20 mM Tris pH 8.0, 150 mM
NaCl prior to final SEC on a Superdex 200 16/60 column (GE
Healthcare).
The Ni–NTA column was subsequently washed with (i)
20 mM Tris pH 8.0, 25 mM NaCl, 5% glycerol, (ii) 20 mM Tris
pH 8.0, 150 mM NaCl, 5% glycerol and (iii) 20 mM Tris pH
8.0, 250 mM NaCl, 2 mM -mercaptoethanol to refold
VcParE2 on the column. VcParE2 was eluted using a step
gradient of imidazole (25, 50, 250 and 500 mM) and was
further purified on a Superdex 75 16/60 column. The purity of
all samples was checked by SDS–PAGE and nano-electro-
spray ionization–time of flight (nESI-TOF) mass spectro-
metry. Macromolecule-production information is summarized
in Table 1.
2.2. Electrophoretic mobility shift assay
A 350 bp DNA fragment comprising the first 67 bp of the
parD2 ORF and extending further upstream into the control
region of the parDE2 operon from V. cholerae biovar El Tor
strain N16961 (NCBI NC_002506.1) was synthesized by PCR-
based gene assembly (Stemmer et al., 1995) after optimization
of the oligonucleotides using the DNAWorks platform
(Hoover & Lubkowski, 2002). The assembled 350 bp fragment
was used as the template for PCR amplification of a 151 bp
fragment comprising the putative operator region upstream of
the parD2 ORF with the oligonucleotides forward (Fw) 50-
TGAGGCGTTTGTTATGCGC and reverse (Rv) 50-TTTGT
ATTTGGCTTGTAATAAAGCCAT as primers, of which one
was 50-32P single-end labelled with (32P)-ATP (Perkin Elmer,
3000 Ci mmol1) and T4 polynucleotide kinase (Thermo
Fisher) as described by Nguyen Le Minh et al. (2018). Labelled
PCR fragments were purified by gel electrophoresis on 6%
polyacrylamide. For electrophoretic mobility shift assays
(EMSAs), increasing concentrations of ParD2 were mixed
with labelled DNA (10 000–15 000 cpm) in buffer consisting of
20 mM Tris pH 8, 150 mM NaCl, 1 mM TCEP in a total
volume of 20 ml and incubated at 20C for 30 min. After
incubation, 3 ml loading buffer (25% Ficoll, 0.1% xylene-
xyanol, 0.1% bromophenol) was added to each sample.
Separation was performed on 6% polyacrylamide gels run in
TBE buffer at 130 V for approximately 3 h.
2.3. Limited proteolysis
VcParD2 at 20 mM was incubated with different molar
ratios of trypsin, proteinase K and subtilisin (1:10, 1:100,
1:1000 and 1:10 000) in 10 mM Tris–HCl pH 8.0, 5 mM CaCl2.
The mixtures were gently vortexed and incubated at 25C.
Samples were taken at different time points (1 min, 15 min, 1 h
and 2 h) and the reaction was stopped by adding quenching
solution (0.1 mM leupeptin, 1 mM AEBSF, 1 mM CaCl2 and a
cOmplete ULTRA protease-inhibitor tablet) followed by
15 min incubation on ice. The samples for SDS–PAGE analysis
were prepared at 1:4 dilution with colourless 4 SDS–PAGE
loading dye (200 mM Tris pH 6.8, 277 mM SDS, 40 mM
glycerol, 50 mM EDTA), boiled for 5 min at 95C and loaded
onto a 4–20% Mini-PROTEAN TGX Precast gel (Bio-Rad).
2.4. Crystallization, data collection and structure
determination
The protein was concentrated to 20 mg ml1 in 20 mM Tris
pH 8.0, 150 mM NaCl. For screening crystallization conditions,
0.1 ml protein solution was mixed with 0.1 ml reservoir solution
in a sitting drop and equilibrated against 100 ml reservoir
solution using a Mosquito HTS robot (SPT Labtech). Crystals
were observed after approximately three months in 0.2 M
lithium sulfate, 0.1 M MES pH 6.0, 20%(w/v) PEG 4000. The
crystals were transferred to precipitant solution supplemented
with 25% PEG 400 for cryoprotection and were immediately
flash-cooled in liquid nitrogen. Crystallization information is
summarized in Table 2. Data were collected on the
PROXIMA-2A beamline at the SOLEIL synchrotron facility,
Gif-sur-Yvette, Paris, France. All data were indexed, inte-
grated and scaled with XDS (Kabsch, 2010) via the XDSME
interface (Legrand, 2017). The solvent content was analyzed
using the CCP4 program MATTHEWS_COEF (Kantardjieff
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Table 1
Macromolecule-production information.
Source organism V. cholerae
DNA source Commercial gene synthesis by GenScript
Cloning vector pET-28a
Expression vector pET-28a
Expression host E. coli BL21 (DE3)








& Rupp, 2003). Data-collection and processing statistics are
summarized in Table 3.
The structure of VcParD2 was determined by molecular
replacement with Phaser-MR (McCoy, 2007) using the dimer
of the N-terminal domain (residues 1–50) of C. crescentus
ParD2 (CcParD2; PDB entry 3kxe; 63% sequence identity;
Dalton & Crosson, 2010). Four copies of the N-terminal
domain dimer were placed in the asymmetric unit. Several
cycles of refinement in Phenix (Liebschner et al., 2019) and
manual model building in Coot (Emsley et al., 2010) improved
the phases. Further iterative cycles were performed in
phenix.refine using an intensity-based maximum-likelihood
target function, including TLS and NCS refinement with
automated group determination as implemented in phenix.
refine. Strong NCS restraints were applied throughout
refinement, leading to a relatively high value for Rwork but a
comparably small difference between Rwork and Rfree. Because
of the low resolution, we assumed that all eight chains were
identical and chose to include the same number of amino
acids. Consequently, rather poor fits for residues 3–4 of some
of the chains remain. Refinement statistics are given in Table 4.
Structural homologs were identified using DALI (http://
ekhidna2.biocenter.helsinki.fi/dali; Holm, 2020). Macro-




Protein concentrations were determined spectrophoto-
metrically assuming extinction coefficients at 280 nm of
2980 M1 cm1 for VcParD2 and 15 470 M1 cm1 for
VcParE2-His as determined from the amino-acid sequences
using the ProtParam tool from the ExPASy server (Gasteiger
et al., 2005). CD spectra were recorded at room temperature
on a Jasco J-715 spectropolarimeter at a concentration of
0.15 mg ml1 in 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM
TCEP.
2.6. Analytical SEC and SEC-MALS
Analytical SEC experiments were performed using
Superdex Increase 200 10/300 and Superdex Increase 75 10/
300 columns (GE Healthcare) equilibrated with 20 mM Tris
pH 8, 500 mM NaCl, 1 mM TCEP. The Bio-Rad gel-filtration
standards (bovine thyroglobulin, 670 kDa; bovine -globulin,
158 kDa; chicken ovalbumin, 44 kDa; horse myoglobin,
17 kDa; vitamin B12, 1.35 kDa) were used to make a standard
curve of the logarithm of the molecular weights of the stan-
dards as a function of their elution volumes.
Multi-angle light-scattering experiments coupled to SEC
(SEC-MALS) were performed using a HPLC system (Waters)
connected inline with a miniDAWN TREOS II (Wyatt Tech-
nology) light-scattering detector (using three angles) followed
by a Shodex refractive-index detector (RI-501). A Shodex
K402.5-4F SEC column was connected to the SEC-MALS
system and equilibrated with 2–3 column volumes of the
corresponding running buffer. A dilution series of VcParD2
samples from 18 to 0.1 mg ml1 was prepared in the same
buffer. 10 ml was injected for each dilution. A BSA sample at
1 mg ml1 was used as a standard for calibration. The data
were processed, and consequently the molar mass was deter-
mined, using the ASTRA 7.1.4 software.
2.7. Native mass spectrometry (MS)
For native MS, ParD2 was transferred into different
concentrations of ammonium acetate (50, 150 and 500 mM) at
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Table 3
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source PROXIMA-2A, SOLEIL
Wavelength (Å) 0.9801
Temperature (K) 100
Detector EIGER X 9M
Crystal-to-detector distance (mm) 404.12
Rotation range per image () 0.1
Total rotation range () 240
Space group C2221
a, b, c (Å) 85.01, 101.70, 107.23
, ,  () 90, 90, 90
Mosaicity () 0.208
Resolution range (Å) 45.95–3.083 (3.193–3.083)
Total No. of reflections 59911 (4033)
No. of unique reflections 8845 (842)








Plate type 96-well Intelli-Plate (Hampton Research)
Temperature (K) 293
Protein concentration (mg ml1) 20
Buffer composition of protein
solution
20 mM Tris pH 8.0, 150 mM NaCl
Composition of reservoir solution 0.2 M lithium sulfate, 0.1 M MES pH 6.0,
20%(w/v) PEG 4000
Volume and ratio of drop 0.2 ml, 1:1
Volume of reservoir (ml) 100
Table 4
Structure solution and refinement.
Values in parentheses are for the outer shell.
Resolution range (Å) 45.95–3.08 (3.19–3.08)
Completeness (%) 99.50 (96.34)
 Cutoff None
No. of reflections, working set 8845 (842)
No. of reflections, test set 442 (42)
Final Rcryst 0.27 (0.35)
Final Rfree 0.29 (0.36)




Average B factor (Å2) 84.57
Ramachandran plot
Most favoured (%) 95.74
Allowed (%) 3.99
Disallowed (%) 0.27
different pH values (8.0 and 5.6) using Biospin buffer-
exchange columns (Bio-Rad, Temse, Belgium). After buffer
exchange, the concentration of the protein in the various
buffer conditions was determined using a NanoDrop P2000
spectrophotometer (Thermo Scientific, Waltham, Massachu-
setts, USA).
For each buffer condition, samples were introduced into the
mass spectrometer at VcParD2 concentrations of 0.1, 1.0 and
2.5 mg ml1. Nano-electrospray ionization (ESI) was
performed using 3–4 ml of sample loaded into home-made
gold-coated borosilicate glass capillaries, with spray voltages
applied in the range +1.5–2.0 kV. The spectra were recorded
on an ion mobility-enabled time-of-flight mass spectrometer
(Synapt G2 HDMS, Waters, Wilmslow, UK). To achieve
gentle, native-like conditions, the instrument parameters were
carefully optimized in order to avoid ion activation and to
preserve the higher order structure of VcParD2 in the mass
spectrometer. The optimized values for VcParD2 are sampling
cone, 50 V; extraction cone, 2 V; trap collision energy, 20 V;
trap DC bias, 45 V; transfer collision energy, 4 V. The pressure
in the source region (backing) and in the trap cell (collision
gas) were 5.5  102 and 3.1  102 mbar, respectively.
Spectra were externally calibrated using a 10 mg ml1 solution
of caesium iodide. Analyses of the acquired spectra were
performed using MassLynx version 4.1 (Waters, Wilmslow,
UK). Native MS spectra were smoothed (to an extent
depending on the size of the complexes) and additionally
centred to calculate the molecular weights.
2.8. Small-angle X-ray scattering
SAXS data were collected on the SWING beamline at
SOLEIL in HPLC mode using an Agilent BioSEC 3-300
column at a protein concentration of 12 mg ml1 in 20 mM
Tris pH 8.0, 150 mM NaCl, 1 mM TCEP at 19C. Protein
samples were briefly spun down before loading onto the SEC
column. 50 ml VcParD2 was injected onto the column at a
constant flow rate of 0.2 ml min1. The final scattering curve
(after buffer subtraction) was generated for each sample after
a range of scattering curves around the peak (with equivalent
Rg values) had been normalized and averaged. The Rg values
were derived from the Guinier approximation at small q
values, while the I(0) parameter was estimated by extrapola-
tion to q = 0 using the ATSAS suite (Manalastas-Cantos et al.,
2021). Molecular weights were determined by the Bayesian
estimation implemented in PRIMUS from the ATSAS suite.
All simulations were performed in Xplor-NIH version 2.49
(Schwieters et al., 2018), starting from the hexadecameric
X-ray structure of VcParD2 solved in this work. Residues that
were not resolved in the X-ray structure, including the disor-
dered C-terminal tail, were added in Xplor-NIH using the
standard topologies for individual amino acids, followed by
minimization of the energy function consisting of the standard
geometric (bonds, angles, dihedrals and impropers) and steric
(van der Waals) terms.
For refinement against the experimental SAXS data, the
positions of the structured protein regions were kept fixed,
while the disordered protein termini (including residues 1–4
and 48–81) were given full degrees of freedom. The compu-
tational protocol comprised an initial simulated-annealing
step followed by side-chain energy minimization as described
previously (Schwieters & Clore, 2014). In addition to the
standard geometric and steric terms, the energy function
included a knowledge-based dihedral angle potential and a
SAXS energy term incorporating the experimental data
(Schwieters & Clore, 2014). Truncated SAXS curves (q <
0.5 Å1) were used as the sole experimental input.
In each refinement run, 100 structures were calculated and
the ten lowest-energy solutions representing the best agree-
ment with the experimental data were retained for subsequent
analysis. The agreement between the experimental and
calculated SAXS curves (obtained with the calcSAXS helper
program, which is part of the Xplor-NIH package) was










where I(q)calc,i and I(q)exp,i are the scattering intensities at a
given q for the calculated and experimental SAXS curves,
I(q)exp,i is an expethemental error on the corresponding
I(q)exp,i value and n is the number of data points defining the
experimental SAXS curve. SAXS experimental details are
given in Table 5.
3. Results
3.1. Purification of VcParD2 and VcParE2
We initially attempted to express VcParD2 in E. coli from a
pET-28a expression vector that adds a C-terminal His tag
followed by a TEV cleavage site. These attempts led to very
poor yields, possibly as a consequence of proteolytic degra-
dation of VcParD2 in the absence of VcParE2. We therefore
altered our strategy and co-expressed VcParD2 and VcParE2
to obtain a VcParD2–VcParE2 complex. In order to obtain
isolated VcParD2 and VcParE2, we used an on-column
unfolding–refolding protocol similar to those developed
previously for Phd/Doc, MazEF and HigBA (Sterckx et al.,
2015). VcParE2 is His-tagged at its C-terminus and the
VcParD2–VcParE2 complex was trapped on an Ni–NTA
column. Firstly, after extensive washing of the column, the
VcParD2–VcParE2 complex was eluted and further cleaned
using SEC on a Superdex 200 column. This step removes
contaminating proteins of lower molecular weight that may
otherwise co-migrate with VcParD2 or VcParE2 in subsequent
steps. Subsequently, the VcParD2–VcParE2 complex was
reloaded onto the Ni–NTA column. VcParD2 can then be
eluted by applying a GndHCl gradient. This allowed us to
prepare VcParD2 in the absence of an affinity tag or other
cloning artefact, ensuring that the quaternary structure is not
affected by the presence of a tag. After elution of VcParD2,
the protein was refolded by dialysis. The refolded protein was
then further polished by SEC on a Superdex 200 column
(Supplementary Fig. S1).
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Our method has the additional advantage that VcParE2 can
also be obtained as, like most other TA toxins, VcParE2
cannot be expressed in the absence of its cognate antitoxin.
The VcParE that remains trapped was refolded on the Ni–NTA
column in a three-step procedure that consists of washing with
(i) 20 mM Tris pH 8.0, 25 mM NaCl, 5% glycerol, (ii) 20 mM
Tris pH 8.0, 150 mM NaCl, 5% glycerol and (iii) 20 mM Tris
pH 8.0, 250 mM NaCl, 2 mM -mercaptoethanol. VcParE2
was subsequently eluted using a step gradient of imidazole.
The resulting protein was then applied onto a Superdex 75
column to obtain a sample that is pure on SDS–PAGE.
3.2. VcParD2 is a well folded DNA-binding protein
Both VcParE2 and VcParD2 show CD spectra that are
compatible with folded proteins (Fig. 1a). VcParD2 is almost
exclusively composed of -helices, while VcParE2 contains
both -helices and -sheets. The SEC profile of VcParE2 is
compatible with a globular monomer (Fig. 1b). VcParD2
nevertheless elutes at an apparent molecular weight of
170 kDa, which is much higher than the 18 kDa expected for a
dimer (Fig. 1c). While the presence of an IDP region will lead
to aberrant migration in SEC, this deviation seems to be too
large to be solely explainable by this phenomenon and a
higher oligomer is likely to be formed. Both elution profiles
are nevertheless indicative of monodisperse samples and
together with the CD spectra suggest correctly folded proteins.
It is also of interest to compare the molecular weight of
VcParD2 with that of the co-expressed VcParD2–VcParE2
complex. The latter elutes from a Superdex Increase 200 10/
300 column at an apparent molecular weight of 96 kDa, which
is significantly smaller than the corresponding value for the
VcParD2 oligomer (Fig. 1c). This indicates that VcParE2
binding at least partially disrupts the VcParD2 oligomer. The
resulting complex is still larger than the corresponding
complex from C. crescentus (44 kDa; Dalton & Crosson, 2010).
In analogy to ParD from plasmid RK2 (RKParD; Roberts et
al., 1993) and ParD2 from M. tuberculosis (Gupta et al., 2016),
we predicted VcParD2 to be a DNA-binding protein that
represses the parDE2 operon. In order to investigate this
hypothesis, EMSA experiments were performed using a
151 bp fragment upstream of the translation start of parD2
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Table 5
SAXS experimental details.
This table has been prepared according to the guidelines given by Trewhella et al. (2017).
(a) Sample details.
Protein name ParD2
Organism V. cholerae O1 El Tor strain
Source/entry Synthetic gene
Sequence MAKNTSITLGEHFDGFITSQIQSGRYGSASEVIRSALRLLENQETKLQSLRQLL
IEGEQSGDADYDLDSFINELDSENIR (UniProt ID P58093)
Extinction coefficient " 2980 M1 cm1 (280 nm)
Partial specific volume  (cm3 g1) 0.742
Mean scattering contrast 	 (cm2) 2.80  1010
Molecular mass M from chemical composition (Da) 8964.84
SEC-SAXS
Loading volume/concentration (mg ml1) 12
Injection volume (ml) 50
Flow rate (ml min1) 0.2
Solvent 20 mM Tris pH 8, 150 mM NaCl, 1 mM TCEP
(b) SAXS data-collection parameters.
Source SWING beamline, SOLEIL synchrotron
Wavelength (Å) 1.03219
Beam size (mm) 200  20 to 500  200 (KB), 20  20 (micro-focus)
Sample-to-detector distance (m) 2.0
q-measurement range (Å1) 0.0054–0.5040
Basis for normalization to constant counts Data were normalized to the intensity of the transmitted beam and radially
averaged; the scattering of the solvent blank was subtracted
Method for monitoring radiation damage Evaluation of Rg values per frame during data collection
Exposure time (s) 0.990
Sample configuration In-line size-exclusion chromatography (SEC) at 0.2 ml min1. Quartz
capillary 1.5 mm diameter.
Sample temperature (C) 19
(c) Software employed for SAXS data reduction, analysis and interpretation.
SAXS data reduction FOXTROT 3.5.2-3645
Calculation of " from sequence ExPASy ProtParam tool
Basic analyses: Guinier, P(r), scattering particle volume PRIMUS from the ATSAS 2.8 package
Atomic structure modelling Xplor-NIH version 2.49
Modelling of missing sequences from PDB files Xplor-NIH version 2.49
Molecular graphics UCSF Chimera
and a 207 bp control fragment derived from the operator
sequence of the Cupriavidus metallidurans psrQ2 gene (Ali et
al., 2020). Clear binding can be observed of VcParD2 to its
own operator region, while no binding is observed to the
psrQ2 operator sequence (Fig. 2). DNA binding therefore
appears to be specific and the experiment thus further vali-
dates the functionality of our VcParD2 preparation. With a
protein concentration of 6 mM or higher required for binding,
this not only corresponds to the same order of magnitude of
binding strength as is typical for many bacterial repressors,
including M. tuberculosis ParD2 (MtParD2; Gupta et al.,
2016), but also indicates that VcParD2 is active as a DNA-
binding protein in its oligomeric state (see below), further
emphasizing the relevance of our structure.
3.3. The VcParD2 monomer and dimer
The VcParD2 sample formed crystals that diffracted to
3.1 Å resolution only after three months. The structure was
determined by molecular replacement using the dimer of the
N-terminal domain of C. crescentus ParD2 (CcParD2; Dalton
& Crosson, 2010), which shows 63% sequence identity to
VcParD2 (54% for the complete protein chain), as a search
model. The structure was refined to an Rwork of 0.2709 and an
Rfree of 0.2988 (Table 4). The asymmetric unit contained four
dimers of the N-terminal domain of VcParD2 and the corre-
sponding models encompass residues Lys3–Arg51. The
N-terminal two and C-terminal 32 residues are not visible in
the electron-density map.
Although we did not succeed in determining the length of
the polypeptide present in the crystal, it is highly unlikely that
eight intact VcParD2 chains are present in the asymmetric
unit. The solvent content calculated based on the visible part
of the VcParD2 chains is 53%, which is a very reasonable
value. In the case of intact 81-amino-acid VcParD2 chains, this
would decrease to 22%. Although such a low solvent content
is not entirely impossible, the estimated probability based on
the distribution of VM values in known crystal structures
(Kantardjieff & Rupp, 2003) is below 1%, and in such a case
the crowded environment would be expected to induce
structure in the IDP region, as is observed for M. tuberculosis
YefM (Kumar et al., 2008) and in part for bacteriophage P1
Phd (Garcia-Pino et al., 2010). Indeed, degradation of the IDP
regions of antitoxins during crystallization has been observed
before (Hadži et al., 2017). Furthermore, limited proteolysis
experiments using trypsin, subtilisin and proteinase K showed
the appearance of faster moving fragments (one or two closely
migrating bands near the buffer front; Supplementary Fig. S2),
which further strengthens the hypothesis that the species we
have crystallized may have originated via slow (over months)
noncontrolled proteolysis.
As expected, the VcParD2 N-terminal domain (VcParD2N)
adopts a ribbon–helix–helix DNA-binding fold (Fig. 3a), with
a C r.m.s.d. of 0.7 Å on 47 equivalent residues to CcParD2N
(Dalton & Crosson, 2010; PDB entry 3kxe). Its topology
consists of four helices in an open array of two hairpins, as
often found in bacterial and phage repressors. In a DALI
search, a number of additional structurally related transcrip-
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Quality-of-fit parameter 0.97 (legacy estimate implemented in PRIMUS/ATSAS)






Quality-of-fit parameter 0.74 (legacy estimate implemented in PRIMUS/ATSAS)
M from I(0) (ratio to expected value) 124000 (1.1)
Volume (Å3) 127962
(e) Atomistic modelling.
Method Simulations in Xplor-NIH based on crystallographic coordinates of the
hexademeric assembly
q-range for fitting (Å1) 0–0.5
2 value 2.11 (average of the ten best dodecameric models)
Adjustable parameters in the model fit Side-chain energy minimization, geometric and steric terms, knowledge-based
dihedral angle potential included in the energy function
Domain/subunit coordinates and contacts, regions of presumed flexibility Positions of the structured protein regions were kept fixed, while the
disordered protein termini (including residues 1–4 and 48–81) were given
full degrees of freedom
( f ) Data and model deposition IDs.
PDB code of crystallographic structure 7b22; PDB files of dodecamer models are available upon request
Table 5 (continued)
tion factors were identified that not only include the expected
N-terminal domain of M. opportunistum ParD3, but also
CopA, the antitoxin from the newly identified type II TA
module ParESO–CopASO from Shewanella oneidensis, the
N-terminal domain of the antitoxin AtaR from the E. coli
AtaT–AtaR TA pair and the non-TA-related 45-residue long
transcriptional repressor CopG from S. agalactiae, as well as
the Arc repressor from Salmonella bacteriophage P22 (Table 6
and Supplementary Fig. S3). Plasmid RK2 ParD, with only 8%
sequence identity, only shows up as a low-ranking hit in this
search.
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Figure 1
VcParE2 and VcParD2 are monodisperse, folded proteins. (a) CD spectra
of 0.15 mg ml1 VcParD2 (grey) and VcParE2-His (black) in 20 mM Tris
pH 8.0, 150 mM NaCl, 1 mM TCEP. (b) Analytical SEC elution profile of
0.15 mg ml1 VcParE2 in 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM TCEP
on a Superdex Increase 75 10/300 column. The elution volumes of the
molecular-weight standards (chicken ovalbumin, 44 kDa; horse
myoglobin, 17 kDa; vitamin B12, 1.35 kDa) are shown as diamonds
together with a linear regression (black line). (c) Analytical SEC elution
profile of 0.1 mg ml1 VcParD2 and the VcParD2–VcParE2 complex in
20 mM Tris pH 8.0, 150 mM NaCl, 1 mM TCEP on a Superdex Increase
200 10/300 column. The elution volumes of the molecular-weight
standards (bovine -globulin, 158 kDa; chicken ovalbumin, 44 kDa;
horse myoglobin, 17 kDa) are shown as diamonds together with a linear
regression (black line).
Figure 2
VcParD2 is a specific DNA-binding protein. (a) EMSA experiment with
VcParD2 titrated against a 151 bp DNA fragment upstream of the ATG
start codon of ParD2. VcParD2 concentrations (in monomer equivalents)
are given at the top in micromolar units. Binding is observed from 6 mM
onwards and involves at least two discrete steps. (b) Equivalent EMSA
using a 207 bp fragment derived from the operator sequence of the
C. metallidurans psrQ2 gene. The VcParD2 concentrations used were
identical to those in (a). No binding was observed for this fragment in the
concentration range tested.
Like other members of the MetJ/CopG/Arc family,
including its homologs from plasmid RK2, M. opportunistum
and C. crescentus, the VcParD2 monomers associate into a
conserved dimer (Figs. 3a and 3b). Dimer formation buries
about 1240 Å2 of mainly hydrophobic surface and creates the
hydrophobic core of the protein. According to the P(iG)
value of 0.37 provided by the PISA server (Krissinel &
Henrick, 2007), the contact surfaces are somewhat more
hydrophobic that the average surface of a soluble protein,
which is in agreement with a dimer that would be stable in
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Table 6












CcParD Caulobacter crescentus 3kxe 7.5 0.7 63 47 Dalton & Crosson (2010)
SoCopA Shewanella oneidensis 6iya 6.2 1.8 20 46 Zhao et al. (2019)
MoParD3 Mesorhizobium opportunistum WSM2075 5ceg 6.1 1.7 17 43 Aakre et al. (2015)
SaCopG Streptococcus agalactiae 2cpg 5.6 1.8 23 43 Gomis-Rüth et al. (1998)
Arc Salmonella bacteriophage P22 1arq 5.4 1.9 7 Bonvin et al. (1994)
EcAtaR Escherichia coli 6ajn,
6gto
5.2 2.1 9 44 Yashiro et al. (2019),
Jurėnas et al. (2019)
RKParD Escherichia coli RK2 plasmid 2an7 4.4 2.1 8 33 Oberer et al. (2007)
Figure 3
Crystal structure of VcParD2. (a) Cartoon representation of the VcParD2 dimer (residues 3–51) in three orientations. One monomer is coloured
according to secondary structure (-strand, yellow; -helices, red; loop regions, green). The second monomer is coloured cyan. (b) Superposition of the
VcParD2N dimer (orange) with the dimers of other RHH-type transcription factors: RKParD (green), CcPArD (purple), MoParD3 (yellow) and
SaCopG (cyan).
solution. Hydrophobic contacts involve contributions from
most nonpolar side chains: Ile7 and Leu9 at the end of the
N-terminal -strand, Phe13 and Phe16 in helix 1 and Ile17,
Ala29, Val32, Ile33, Ala36, Leu37, Leu39 and Leu40 in helix
2. Most notable is the close contact between the 213 helices
of both chains, in which Ala36 seems to be essential, with any
other residue except for glycine at this position resulting in
steric crowding. Further stabilization arises via hydrogen
bonds, most importantly via pairing of the N-terminal
-strands.
3.4. Higher order structure in the crystal
In the crystal, the VcParD2N dimers are found in a circular
arrangement. This results in a torus consisting of eight
VcParD22 dimers (Fig. 4). The interface formed by adjacent
VcParD22 dimers buries roughly 600 Å
2. This interface is
highly hydrophilic [PISA P(iG) value of 0.91] and is domi-
nated by hydrogen bonds and salt bridges, and as such deviates
from typical stable oligomerization interfaces (Fig. 5a). The
interface is formed by seven amino-acid side chains: Arg25,
Tyr26, Glu31, Arg34, Arg38, Glu41 and Asn42. These side
chains are mostly involved in inter-side-chain hydrogen bonds
or salt bridges (between Glu41 and Arg25 and between Glu31
and Arg34 as well as Arg38) and cation–
 stacking between
Arg38 and Tyr26. The only hydrogen bond involving a main-
chain atom is between the main-chain carbonyl of Arg25 and
the side chain of Arg34. Also of interest is the close contact
between the side chains of Arg38 in both chains, with their
NH2 atoms being only 3.1 Å apart. This, together with the
dominance of side chain–side chain interactions (which are
entropically less favourable than main chain–main chain
interactions), would normally lead us to conclude that this
interface only corresponds to a packing contact and is unlikely
to exist in solution.
The amino acids contributing to this interface are retained
in CcParD, which has previously been shown to be a dimer in
solution (Dalton & Crosson, 2010). The only substitution
among the residues involved in the inter-dimer interface is
Asn42, which is Glu43 in CcParD. This substitution forces
Glu42 of CcParD into a different conformation to the
equivalent Glu41 in VcParD2 in order to separate the two
negative charges. This substitution would also result in an
interface with a net negative charge of 2. Another poten-
tially relevant difference between VcParD2 and CcParD is the
reorientation of Arg38 (Arg39 in CcParD), which now inter-
acts with Glu43 of CcParD. This further results in an ‘inwards’
movement of Arg26 of CcParD (Arg25 of VcParD2) to fill the
space vacated by Arg39. The resulting theoretical interface
would then be destabilized by close contacts between the
positively charged side chains of Arg26 and Arg39 in the
adjacent polypeptide chains.
The hole at the centre of the torus has a diameter of about
16 Å. The C-termini of the 16 VcParD2 N-terminal domains
point outwards from the middle of the side surface of the
torus. If this arrangement were composed of intact VcParD2
chains, the C-terminal IDP regions (residues Leu52–Arg81)
would be forced to adopt a fan-shaped ensemble that is limited
in its conformational variability. In contrast, in RKParD as
well as in CcdA the C-terminal IDP ensemble adopts a wide
range of conformations, many of them sterically incompatible
with the oligomerization of the VcParD2 N-terminal domains
into the torus observed in the crystal (Madl et al., 2006; Oberer
et al., 2007). It is therefore safe to state that the IDP region
would provide an entropic penalty for VcParD2 oligomeriza-
tion similar to that observed in the influence of the IDP region
of Phd on operator binding (Garcia-Pino et al., 2016).
The VcParD2 hexadecamer resembles the crystallographic
assembly of S. agalactiae CopG, which forms a spiral structure
with inter-dimer contact surfaces roughly corresponding to the
inter-dimer interfaces seen in the VcParD2 hexadecamer
(Fig. 5b; Gomis-Rüth et al., 1998). In contrast to VcParD2,
although similar in size, the oligomerization interface of
SaCopG is much more hydrophobic [PISA P(iG) value of
0.38] and is retained in the complex of tetrameric SaCopG
with its operator (Gomis-Rüth et al., 1998; Costa et al., 2001).
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Figure 4
Higher order oligomeric structure of VcParD2N. Two orientations of a
cartoon representation of the hexadecamer of VcParD2 as seen in the
crystal. VcParD2 dimers are alternately coloured pink and blue.
Yet in solution, in the absence of a DNA ligand, SaCopG
behaves as a dimer.
3.5. DNA-binding site
In general, transcription factors of the ribbon–helix–helix
family dock with their N-terminal strands into the major
groove of their target DNA. In agreement with this, the
N-terminal -ribbons present a positively charged electro-
static surface on the VcParD2 dimer that can complement the
negative charges of the DNA backbone.
S. agalactiae CopG (SaCopG) is the closest structural
relative of VcParD2 for which a structure of a DNA complex is
available. SaCopG makes base-pair-specific contacts via the
side chains of Arg4 and Thr6, while hydrogen bonds to the
DNA backbone are provided by the side chains of Thr8, Lys28
and Ser29 (Gomis-Rüth et al., 1998; PDB entry 1b01). In
VcParD2, the corresponding residues are Asn4, Ser6, Thr8,
Ser29 and Ser31, indicating potential differences in DNA
specificity between the two proteins (Supplementary Fig. 3a).
Unfortunately, the target sequence of VcParD2 currently
remains unknown.
SaCopG binds its operator in a chain-like fashion. Several
dimers position themselves next to each other in a similar way
to that seen in the crystal packing of the free SaCopG struc-
ture, with the DNA wrapping around the protein helix (Costa
et al., 2001). In contrast to SaCopG, VcParD2 does not
associate into a helical structure, but forms a closed circle. The
dimer–dimer association of VcParD2 is nevertheless very
similar to that of SaCopG bound to DNA (Fig. 6a), suggesting
that crystal packing may also reflect associations occurring on
the DNA here. Indeed, on the toroidal surface of the VcParD2
crystallographic hexadecamer, the N-terminal -strands stick
out as a set of eight parallel and equally spaced ridges that
lead to a cogwheel-like arrangement (Figs. 3 and 5). Fig. 6(b)
shows the positioning of an 18 bp fragment with a two-
nucleotide overhang taken from an SaCopG–DNA complex
and covering two SaCopG dimers on the surface of the
VcParD2 oligomer (Fig. 6a). When superimposed on
VcParD2, the helical axis of the DNA is tangential to the
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Figure 5
Inter-dimer interface. (a) Cartoon representation of the VcParD2 tetramer. Each chain is coloured differently. Side chains involved in inter-dimer
contacts are shown in stick representation and are shown enlarged at the bottom. The contacts are dominated by hydrogen bonds and salt bridges. (b)
Cartoon representation of the SaCopG tetramer as found in the SaCopG–DNA complex and shown in a similar orientation as VcParD2. The details of
the interacting side chains are again shown enlarged at the bottom. The inter-dimer contacts almost exclusively involve hydrophobic van de Waals
interactions.
cogwheel surface, and the subsequent -strand ridges are
spaced so as to make it possible for a double-stranded DNA to
wrap around the cogwheel. Thus, it is likely that the oligo-
merization mode of VcParD2 may reflect how it interacts with
its operator.
3.6. Oligomerization in solution
Despite the fact that there are several arguments that
disfavour the existence of the crystalline oligomeric assembly
in solution, during the purification of VcParD2 we observed
that it elutes from a Superdex Increase 200 10/300 SEC
column at an appreciably higher molecular weight than is
expected for a simple dimer, even if we take into account the
fact that the IDP region would substantially increase its
hydrodynamic radius. To evaluate the relevance of the
oligomer seen in the crystal, we determined the oligomeric
state of VcParD2 in solution using SEC-MALS and native
mass spectrometry.
To obtain a better estimate of the true oligomeric state in
solution and how it may be affected by the concentration, we
turned to SEC-MALS. A concentration series of VcParD2
ranging from 18 to 0.1 mg ml1 was injected into a Shodex
KW402.5-4F column. At all concentrations, a single peak was
observed at an elution volume indicating a higher order
oligomer (Fig. 7, Supplementary Table S1, Supplementary Fig.
S4). The molecular weight determined for the protein eluting
in this peak ranges from 100.0  0.6 kDa for the highest
concentration used to 78.5  0.6 kDa for the lowest concen-
tration used. No additional peaks were observed that could be
attributed to a monomer or dimer. Given that the theoretical
molecular weight for a VcParD2 dimer is 17 912 Da and that it
can be assumed that the oligomeric state of VcParD2 is a
multiple of a dimer, the SEC-MALS data indicate the
presence of mainly decamers, which are likely to be in equi-
librium with dodecamers and octamers.
Little dependence on concentration or ionic strength was
observed, although lower concentrations tend to give some-
what lower average molecular weights. Similarly, a lower pH
leads to a somewhat higher average molecular weight. Most
important, however, is that even at the highest concentration
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Figure 7
SEC-MALS. (a) A typical SEC-MALS run (10 mg ml1 VcParD2, 20 mM
Tris pH 8.0, 150 mM NaCl, 1 mM TCEP). The observed elution peak and
plateau for molecular mass is representative of all conditions tested. (b)
MALS-derived molecular weights as a function of concentration and
experimental conditions. No clear dependence on concentration or ionic
strength is observed. The molecular-mass values at pH 5.6 are
nevertheless systematically higher than for the measurements at pH 8.0.
Figure 6
DNA-binding site. (a) Complex of SaCopG with an 18 bp DNA fragment.
(b) Model of VcParD2 (surface representation as in Fig. 3a) in complex
with DNA. The SaCopG tetramer was superimposed on two adjacent
dimers of VcParD2. The DNA fragment bound to SaCopG fits onto the
surface of VcParD2 with the N-terminal -strands inserted into the major
groove of the DNA.
used the experimental molecular weight is significantly less
than that of a hexadecamer (as suggested from the crystal
structure). This deviation from the expected molecular weight
is not due to degradation of the C-termini, as nESI-TOF mass
spectra of the protein sample after performing the SEC-
MALS experiments showed the protein to be intact, with no
signs of degradation.
To further understand the true nature of the higher order
complexes that are present in solution, we performed native
mass spectrometry (Fig. 8, Supplementary Fig. S5). These data
nicely mirror the results obtained using SEC-MALS and show
that VcParD2 is predominantly present as a mixture of
decamers and dodecamers in solution, with tetramers as a
third species. Similar to the observations using SEC-MALS, a
lower pH favours the dodecameric assembly. At the lowest
concentration (0.1 mg ml1), some monomers, tetramers and a
very small amount of dimers can nevertheless also be seen, but
decamers and dodecamers still dominate, indicating that these
are indeed stable species. The stability of the decamers and
dodecamers, particularly at high ionic strength, is surprising
given the electrostatic nature of the inter-dimer contact
interface, as also is the lack of substantial amounts of tetra-
mers, hexamers or octamers. We do not observe the presence
of tetradecamers or the hexadecamer that would be expected
from the crystal structure.
3.7. Solution SAXS model of the VcParD2 oligomer
In order to obtain a more detailed picture of the oligomeric
species in solution, we turned to small-angle X-ray scattering
(SAXS). The protein used in this experiment was again
confirmed to be intact using nESI-TOF mass spectrometry,
and therefore a significant fraction of its polypeptide (27%) is
expected to be present in a disordered ensemble. SAXS data
collected on the SWING beamline at SOLEIL were of high
quality up to a q value of 0.5 (Fig. 9a and Table 5). The Guinier
plot shows linear behaviour (R2 = 0.97), rendering a radius of
gyration of 33.64  0.34 Å. However, the dimensionless
Kratky plot of VcParD2 does not reveal the disordered nature
of the C-terminal regions (Supplementary Fig. S6). Its bell-
shaped curve with a maximum around (1.73, 1.1) agrees with
the expected values for a globular particle. The P(r) function
shows a nice bell shape and converges smoothly to zero, with a
good fit at low q angles, indicative of a polydisperse sample
(Manalastas-Cantos et al., 2021).
SAXS data for the VcParD2 antitoxin indicate a molecular
mass of approximately 109 kDa from the Bayesian estimate
implemented in the ATSAS suite (Manalastas-Cantos et al.,
2021). The oligomeric state suggested by this molecular mass
thus corresponds to a dodecamer. The sample used in these
experiments was subsequently verified by nESI-TOF mass
spectrometry and was shown to consist only of intact chains. In
agreement with this observation, the theoretical SAXS curve
calculated for the hexadecameric crystallographic assembly
does not fit the experimental scattering curve (2 = 28.16).
Equally, the full-length protein in this hexadecameric
assembly, with an ensemble in which residues 5–47 are fixed
and residues 1–4 and 48–81 are given full torsional degrees of
freedom, still provides a poor fit (2 = 7.80). In this ensemble,
the IDP tails tend to plug the central hole, rendering the whole
particle more globular. While these solutions are physically
possible (there are very few, if any van der Waals clashes,
torsion angles are good and local geometry is perfect), they do
not make sense biochemically. Entropic considerations make
such a structure, with the tails crammed up in the middle,
highly unlikely.
We then considered a number of ensembles consisting of
full-length VcParD2 chains in octameric, decameric, dodeca-
meric and tetradecameric arrangements. As seen in Fig. 9(b),
the best agreement is obtained for a dodecamer that forms an
open fragment of a torus with identical relative orientations of
the contacts between adjacent dimers as seen in the hexa-
decameric arrangement in the crystal (2 = 2.11). This
ensemble features a realistic spread of tails, with some of them
visiting the central inter-domain region (the former central
hole) and others flopping about on the periphery (Fig. 9c).
Nevertheless, similar decameric and tetradecameric models
also fit reasonably well (2 = 2.58 and 2.78, respectively) and
therefore cannot be excluded. Hybrid models containing
increasing fractions of decameric structures added to the
dodecameric ensemble do not further improve the fit. In other
words, the dodecameric ensemble on its own is sufficient to
explain the scattering data and is most likely to be the domi-
nant species present in solution.
4. Discussion
We were able to obtain correctly folded VcParD2 from the
overexpressed VcParD2–VcParE2 complex via an on-column
unfolding–refolding procedure and showed that the resulting
protein interacts specifically with a 151 bp DNA segment
upstream of the ATG start codon of the parD2 gene. Tran-
scription regulation of parDE modules has also been investi-
gated for parDE on E. coli plasmid RK2 and parDE2 on the
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Figure 8
Native mass spectrometry. The native mass spectrum of VcParD2
(2.5 mg ml1) in 150 mM ammonium acetate pH 8.0 is shown with the
major peaks labelled according to their charge states. The major species
present are decamers and dodecamers, with smaller amounts of
monomers, dimers and tetramers also being observed.
chromosome of M. tuberculosis H37Rv. For plasmid RK2
parDE, the antitoxin RKParD is responsible for auto-repres-
sion of the operon, with two RKParD dimers binding to the
operator. In contrast to most other TA families, RKParE does
not seem to modulate RKParD-mediated repression in vivo
(Roberts et al., 1993; Johnson et al., 1996; Oberer et al., 1999).
In the case of M. tuberculosis parDE2, MtParD2 also represses
the operon on its own, but the presence of MtParE2 reduces
repression in vivo (Gupta et al., 2016). Previous in vivo data
from the V. cholerae parDE2 module are in line with those for
plasmid RK2 parDE, with VcParE2 not being involved in
auto-regulation (Yuan et al., 2011). Our in vitro DNA-binding
results are in line with the results for the homologous parDE
modules located on plasmid RK2 and the M. tuberculosis
chromosome. The affinity of VcParD2 is in the low-micro-
molar range and its higher order oligomeric structure suggests
multiple adjacent binding sites, as is also the case for RKParD,
although the latter is a dimer in solution.
The folded domains of VcParD2 form a partial doughnut
structure in solution that is stabilized via strong electrostatic
interactions. While not recognized as such by the PISA server
(Krissinel & Henrick, 2007), this association is stable and is
maintained even at low protein concentrations. For over four
decades, hydrophobicity, together with complementarity, has
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Figure 9
Small-angle X-ray scattering. (a) Experimental SAXS data (black) overlaid with the theoretical scattering curve for a VcParD2 dodecamer averaged
over the ten best-fitting conformations (red; 2 = 2.11) and the curve calculated for the hexadecameric crystallographic assembly (cyan). (b) 2 values for
the best fits of octameric, decameric, dodecameric, tetradecameric and hexadecameric ensembles. A minimum is seen for a dodecameric ensemble. (c)
Molecular model of the dodecameric ensemble that best represents the scattering data. The folded parts of VcParD2 dimers are alternately shown in blue
and pink. The IDP tails are shown in grey.
been believed to be the major factor stabilizing protein–
protein association (Chothia & Janin, 1975). Contact surfaces
in protein oligomers differ from the rest of the subunit surface
in that they are enriched in hydrophobic side chains and have
a low density of inter-subunit hydrogen bonds (Janin et al.,
1988; Lo Conte et al., 1999). In small dimeric proteins, the
dimer interface often corresponds to the hydrophobic core
and dimerization is essential to form a stable structure.
In contrast, high-affinity electrostatic interactions are
known between IDPs, for example the disordered complex
formed between histone H1 and its chaperone prothymosin-
(Borgia et al., 2018). Similar poly-electrolytic interactions have
also been postulated to drive the formation of membraneless
organelles via liquid–liquid phase transitions (Brangwynne et
al., 2015; Schuler et al., 2020). On the other hand, to find a
stable association of globular proteins dominated by side
chain–side chain hydrogen bonds and electrostatic inter-
actions is highly unusual. To our knowledge, no other exam-
ples of such complexes are known, and the VcParD2 oligomer
thus represents an example of a rare class of protein–protein
interface. The stability of this oligomer is even more surprising
when one considers that the amino acids involved in this
interaction are highly conserved in CcParD from C. crescentus,
with the only difference being the substitution of an aspar-
agine by a glutamate in CcParD. The latter would bury two
negative charges at the inter-dimer interface, creating a highly
unstable situation.
In the crystal, the globular domain of VcParD2 forms a
closed doughnut-shaped structure in the absence of its IDP
tail, which most likely degraded in the two months that were
required for crystals to appear. In the absence of any coop-
erativity, one would expect that with identical interactions
between all dimers, a complete circle would also be formed in
solution. Nevertheless, we were able to demonstrate that the
doughnut is incomplete in solution and that the assembly
consists of 5–6 VcParD2 dimers instead of eight. This implies
the existence of negative cooperativity that prevents forma-
tion of the closed structure. It is likely that this negative
cooperativity originates from the IDP tails, which in a full
hexadecameric assembly would hinder each other’s freedom
and create an entropic barrier that prevents an oligomer larger
than a dodecamer from forming. A similar entropic exclusion
principle has previously been observed for the binding of Phd
to its operator (Garcia-Pino et al., 2016). Two copies of the Phd
dimer need to bind at adjacent sites, but this is prevented due
to entropic exclusion of the IDP tails. Only when Doc binds
and folds these IDP tails can operator binding proceed with
high affinity and the phd/doc operon be repressed. This
mechanism is further related to the action of entropic bristles,
which are IDP tails that can act as solubilizers to prevent
aggregation (Santner et al., 2012), tune prion nucleation
(Michiels et al., 2020) and tune the energy landscape of
proteins in general with respect to protein assemblies and
ligand binding and association (Keul et al., 2018; Niemeyer et
al., 2020).
The similarities in higher order association between
VcParD2 and SaCopG from S. agalactiae suggest a mechanism
for DNA binding. VcParD2 and SaCopG make higher order
contacts via the same spatial surface, although this surface is
substantially more hydrophobic in SaCopG. This association
in SaCopG leads to an extended DNA-binding surface where
multiple SaCopG dimers dock next to each other on the
operator. In many TA systems, the antitoxin often binds to two
or more binding sites on the operator. In most cases, the toxin
increases antitoxin–DNA affinity by bridging adjacent anti-
toxin dimers (Garcia-Pino et al., 2010; Vandervelde et al., 2017;
Xue et al., 2020) or by otherwise stabilizing the DNA-binding
assembly of the antitoxin (Bøggild et al., 2012; Qian et al.,
2019; Jurėnas et al., 2019). Higher toxin:antitoxin ratios lead to
de-repression via the formation of toxin–antitoxin complexes
with altered stoichiometry. For antitoxins that only bind to a
single site, regulation is less complex and the toxin only serves
to weaken operator binding (Brown et al., 2013; Turnbull &
Gerdes, 2017; Winter et al., 2018; Manav et al., 2019). For
parDE modules, the mechanism of transcription regulation is
not known. Early studies of the parDE system present on
plasmid RK2 indicated that the antitoxin is sufficient to
repress the operon and is likely to bind on two adjacent
palindromes (Roberts et al., 1993). Although the operator of
the V. cholerae parDE2 operon is not known, the higher order
association of VcParD2 dimers suggests cooperative binding
to the DNA in a similar way to that observed for SaCopG. The
extent to which the corresponding toxin influences this inter-
action currently remains unknown.
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